A carregar...

A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents

Background: The large majority of patients with multiple myeloma develop bone lesions and typically receive bisphosphonates to maintain bone health and prevent/delay skeletal-related events. Recent clinical data show that the newer-generation bisphosphonate, zoledronic acid, may confer a survival be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ria, Roberto, Reale, Antonia, Moschetta, Michele, Mangialardi, Giuseppe, Dammacco, Franco, Vacca, Angelo
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515976/
https://ncbi.nlm.nih.gov/pubmed/23236556
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!